Showing 691-700 of 23022 results for "".
PROMs in Clinical Practice: Impacting Treatment Decisions
https://reachmd.com/programs/cme/proms-in-clinical-practice-impacting-treatment-decisions/33243/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.Patient-Reported Outcome Measures (PROMs): Valuable Insights Into the Lived Experience of PAH
https://reachmd.com/programs/cme/patient-reported-outcome-measures-proms-valuable-insights-into-the-lived-experience-of-pah/33240/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.MS Minute: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/32180/MOGAD, an inflammatory demyelinating disease of the central nervous system, has some overlapping clinical features with NMOSD and MS but is a distinct entity with unique pathologic, clinical, and imaging features.Current & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults
https://reachmd.com/programs/cme/current-emerging-therapies-treating-preventing-hereditary-angioedema-attacks-in-children-adults/37604/Provided by RMEI Medical Education, LLC. Supported by independent educational grants from Intellia Therapeutics, Pharming Healthcare, Inc., and Pharvaris.Chairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates
https://reachmd.com/programs/cme/chairperson-perspective-improving-hrher2-breast-cancer-outcomes-with-trop2-antibody-drug-conjugates/29875/Learn about TROP2-directed antibody-drug conjugates and their role in the treatment of HR+, HER2- metastatic breast cancer.Managing Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care
https://reachmd.com/programs/medical-industry-feature/managing-capillary-leak-syndrome-early-recognition-and-intervention-in-bpdcn-care/29929/Capillary leak syndrome is a significant adverse event of blastic plasmacytoid dendritic cell neoplasm therapy. Here’s how to recognize and treat it.From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
https://reachmd.com/programs/cme/from-late-line-rescue-to-early-line-option-the-potential-for-bispecific-antibodies-in-multiple-myeloma/49264/Explore how bispecific antibodies are moving earlier in the treatment paradigm of multiple myeloma, supported by pivotal data showing improved patient outcomes.Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
https://reachmd.com/programs/cme/advancing-care-in-hnscc-evolving-strategies-across-the-disease-continuum/48999/Experts explain how emerging clinical data and novel therapeutic strategies in HNSCC can expand our treatment armamentarium and improve patient outcomes.Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
https://reachmd.com/programs/cme/optimizing-igan-care-achieving-lower-proteinuria-targets-with-combination-therapy/26631/Review data on combination therapy with sparsentan and SGLT2 inhibitors to achieve lower proteinuria in patients with IgA nephropathy.Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
https://reachmd.com/programs/cme/expert-perspectives-from-aua-2025-contextualizing-the-evolving-landscape-of-bladder-cancer/33076/Explore expert insights from AUA 2025 on advancing bladder cancer care, with updates on NMIBC treatment and biomarker-driven strategies.